Abstract
Temporal bone paragangliomas (TBPs) are slow-growing, highly vascular primary neoplasms of the middle ear and lateral skull base that are composed of paraganglion cells derived from the neural crest. Paraganglioma can be found throughout the body, though in the temporal bone, two forms predominate: tympanic paraganglioma (TP) that originate in the middle ear cleft along the tympanic plexus associated with Jacobson’s (IX) and Arnold’s (X) nerves and jugular paraganglioma (JP) derived from chief cells located in the adventitia of the jugular bulb (Moore et al, Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg 54(4):597–605, 2016; Carlson et al, Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg 152(1):98–105, 2015; Wanna et al, Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg 151(6):991–995, 2014; Langerman et al, Arch Otolaryngol – Head Neck Surg 138(4):341–345, 2012; Jackson et al, Arch Otolaryngol;108(7):401–410, 1982). Most TBP are solitary, non-biochemically secreting and benign, while less than 5% are associated with catecholamine release or malignant character; up to 17% of patients display multiple paragangliomas (Jackson et al, Am J Surg 59(4):389–393, 1990). TBP exhibit a female predominance and most commonly manifest during the fourth to fifth decades of life with symptoms of unilateral pulsatile tinnitus, conductive hearing loss, and less commonly lower cranial neuropathy. Owing to the rare prevalence and typical insidious growth, many patients endorse a long duration of symptoms at diagnosis (Moore et al, Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg 54(4):597–605, 2016; Carlson et al, Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg 152(1):98–105, 2015).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and neck paragangliomas: an update on evaluation and management. Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2016;154(4):597–605.
**Carlson ML, Sweeney AD, Wanna GB, Netterville JL, Haynes DS. Natural history of glomus jugulare: a review of 16 tumors managed with primary observation. Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2015;152(1):98–105.
Wanna GB, Sweeney AD, Carlson ML, et al. Subtotal resection for management of large jugular paragangliomas with functional lower cranial nerves. Otolaryngol – Head Neck Surg: Off J Am Acad Otolaryngol-Head Neck Surg. 2014;151(6):991–5.
Langerman A, Athavale SM, Rangarajan SV, Sinard RJ, Netterville JL. Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol – Head Neck Surg. 2012;138(4):341–5.
Jackson CG, Glasscock ME 3rd, Harris PF. Glomus tumors. Diagnosis, classification, and management of large lesions. Arch Otolaryngol. 1982;108(7):401–10.
Jackson CG, Harris PF, Glasscock ME 3rd, et al. Diagnosis and management of paragangliomas of the skull base. Am J Surg. 1990;159(4):389–93.
Jackson CG, Haynes DS, Walker PA, Glasscock ME 3rd, Storper IS, Josey AF. Hearing conservation in surgery for glomus jugulare tumors. Am J Otolaryngol. 1996;17(3):425–37.
**Oldring D, Fisch U. Glomus tumors of the temporal region: surgical therapy. Am J Otolaryngol. 1979;1(1):7–18.
**Fisch U. Infratemporal fossa approach to tumours of the temporal bone and base of the skull. J Laryngol Otol. 1978;92(11):949–67.
Bacciu A, Ait Mimoune H, D’Orazio F, Vitullo F, Russo A, Sanna M. Management of facial nerve in surgical treatment of previously untreated fisch class C tympanojugular paragangliomas: long-term results. J Neurol Surg Part B, Skull Base. 2014;75(1):1–7.
Bacciu A, Medina M, Ait Mimoune H, et al. Lower cranial nerves function after surgical treatment of Fisch Class C and D tympanojugular paragangliomas. Eur Arch Oto-Rhino-Laryngol: Off J Eur Fed Oto-Rhino-Laryngological Soc. 2013;272:311–9.
Jackson CG, McGrew BM, Forest JA, Netterville JL, Hampf CF, Glasscock ME 3rd. Lateral skull base surgery for glomus tumors: long-term control. Otol Neurotol: Off Publ Am Otological Soc, Am Neurotol Soc Eur Acad Otol Neurotol. 2001;22(3):377–82.
van der Mey AG, Frijns JH, Cornelisse CJ, et al. Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol. 1992;101(8):635–42.
Spector GJ, Maisel RH, Ogura JH. Glomus tumors in the middle ear. I. An analysis of 46 patients. Laryngoscope. 1973;83(10):1652–72.
**Hawthorne MR, Makek MS, Harris JP, Fisch U. The histopathological and clinical features of irradiated and nonirradiated temporal paragangliomas. Laryngoscope. 1988;98(3):325–31.
**Brackmann DE, House WF, Terry R, et al. Glomus jugulare tumors: effect of irradiation. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:1423–31.
Foote RL, Coffey RJ, Gorman DA, et al. Stereotactic radiosurgery for glomus jugulare tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1997;38(3):491–5.
Cosetti M, Linstrom C, Alexiades G, Tessema B, Parisier S. Glomus tumors in patients of advanced age: a conservative approach. Laryngoscope. 2008;118(2):270–4.
Willen SN, Einstein DB, Maciunas RJ, Megerian CA. Treatment of glomus jugulare tumors in patients with advanced age: planned limited surgical resection followed by staged gamma knife radiosurgery: a preliminary report. Otol Neurotol: Off Publ Am Otological Soc, Am Neurotol Soc Eur Acad Otol Neurotol. 2005;26(6):1229–34.
***Ivan ME, Sughrue ME, Clark AJ, et al. A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg. 2011;114(5):1299–305.
***Sheehan JP, Tanaka S, Link MJ, et al. Gamma Knife surgery for the management of glomus tumors: a multicenter study. J Neurosurg. 2012;117(2):246–54.
Miller T, Lau T, Vasan R, et al. Reporting success rates in the treatment of vestibular schwannomas: are we accounting for the natural history? J Clin Neurosci: Off J Neurosurg Soc Australas. 2014;21:914–8.
Prasad SC, Mimoune HA, D’Orazio F, et al. The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas. Otol Neurotol: Off Publ Am Otological Soc, Am Neurotol Soc Eur Acad Otol Neurotol. 2014;35(5):922–31.
Jansen JC, van den Berg R, Kuiper A, van der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88(12):2811–6.
Fisch U. Neurological surgery of the ear. Birmingham: Aesculapius; 1977.
Jackson CGLJ, Marz SJ. Glasscock-Shambaugh surgery of the ear. 6th ed. Shelton: People’s Medical Publishing House; 2010.
Niemann S, Becker-Follmann J, Nurnberg G, et al. Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma. Am J Med Genet. 2001;98:32–6.
**Milunsky J, DeStefano AL, Huang XL, et al. Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet. 1997;72(1):66–70.
Borsanyi SJ. Glomus jugulare tumors. Laryngoscope. 1962;72:1336–45.
Mariman EC, van Beersum SE, Cremers CW, Struycken PM, Ropers HH. Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet. 1995;95(1):56–62.
**Bjorklund P, Pacak K, Crona J. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. J Intern Med. 2016;280:559–7.
Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol. 2004;40(6):563–75.
**Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292(8):943–51.
**Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA. 2005;294(16):2057–63.
Hoekstra AS, van den Ende B, Julia XP, et al. Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma. Clin Genet. 2016;91:536–44.
Boedeker CC, Neumann HP, Maier W, Bausch B, Schipper J, Ridder GJ. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg. 2007;137(1):126–9.
Manolidis S, Shohet JA, Jackson CG, Glasscock ME 3rd. Malignant glomus tumors. Laryngoscope. 1999;109(1):30–4.
Kahn LB. Vagal body tumor (nonchromaffin paraganglioma, chemodectoma, and carotid body-like tumor) with cervical node metastasis and familial association: ultrastructural study and review. Cancer. 1976;38(6):2367–77.
Lattes R, Waltner JG. Nonchromaffin paraganglioma of the middle ear; carotid-body-like tumor; glomus-jugulare tumor. Cancer. 1949;2(3):447–68.
Cotran RA. Pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2005.
**Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730–7.
Schwaber MK, Glasscock ME, Nissen AJ, Jackson CG, Smith PG. Diagnosis and management of catecholamine secreting glomus tumors. Laryngoscope. 1984;94(8):1008–15.
***Lawson W. The neuroendocrine nature of the glomus cells: an experimental, ultrastructural, and histochemical tissue culture study. Laryngoscope. 1980;90(1):120–44.
Parkinson D. Intracranial pheochromocytomas (active glomus jugulare). Case report. J Neurosurg. 1969;31(1):94–100.
Papaspyrou K, Mewes T, Toth M, Schmidtmann I, Amedee RG, Mann WJ. Hearing results after hypotympanotomy for glomus tympanicum tumors. Otol Neurotol. 2011;32(2):291–6.
Jackson CG, Welling DB, Chironis P, Glasscock ME 3rd, Woods CI. Glomus tympanicum tumors: contemporary concepts in conservation surgery. Laryngoscope. 1989;99(9):875–84.
**Carlson ML, Sweeney AD, Pelosi S, Wanna GB, Glasscock ME 3rd, Haynes DS. Glomus tympanicum: a review of 115 cases over 4 decades. Otolaryngol Head Neck Surg. 2015;152(1):136–42.
Durvasula VS, De R, Baguley DM, Moffat DA. Laser excision of glomus tympanicum tumours: long-term results. Eur Arch Otorhinolaryngol. 2005;262(4):325–7.
Molony NC, Salto-Tellez M, Grant WE. KTP laser assisted excision of glomus tympanicum. J Laryngol Otol. 1998;112(10):956–8.
Robinson PJ, Grant HR, Bown SG. NdYAG laser treatment of a glomus tympanicum tumour. J Laryngol Otol. 1993;107(3):236–7.
Guild SR. The glomus jugulare, a nonchromaffin paraganglion, in man. Ann Otol Rhinol Laryngol. 1953;62(4):1045–71; concld.
Sanna M, Jain Y, De Donato G, Rohit LL, Taibah A. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol: Off Publ Am Otological Soc, Am Neurotol Soc Eur Acad Otol Neurotol. 2004;25(5):797–804.
Moe KS, Li D, Linder TE, Schmid S, Fisch U. An update on the surgical treatment of temporal bone paraganglioma. Skull Base Surg. 1999;9(3):185–94.
Bacciu A, Medina M, Ait Mimoune H, et al. Lower cranial nerves function after surgical treatment of Fisch Class C and D tympanojugular paragangliomas. Eur Arch Oto-Rhino-Laryngology: Off J Eur Fed Oto-Rhino-Laryngological Soc. 2015;272(2):311–9.
Kaylie DM, O’Malley M, Aulino JM, Jackson CG. Neurotologic surgery for glomus tumors. Otolaryngol Clin N Am. 2007;40(3):625–49, x.
Netterville JL, Civantos FJ. Rehabilitation of cranial nerve deficits after neurotologic skull base surgery. Laryngoscope. 1993;103(11 Pt 2 Suppl 60):45–54.
Carlson ML, Driscoll CL, Garcia JJ, Janus JR, Link MJ. Surgical management of giant transdural glomus jugulare tumors with cerebellar and brainstem compression. J Neurol Surg Part B, Skull Base. 2012;73(3):197–207.
Schuster D, Sweeney AD, Stavas MJ, et al. Initial radiographic tumor control is similar following single or multi-fractionated stereotactic radiosurgery for jugular paragangliomas. Am J Otolaryngol. 2016;37(3):255–8.
***Guss ZD, Batra S, Limb CJ, et al. Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys. 2011;81(4):e497–502.
Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck. 2002;24(4):332–8; discussion 338–339.
Pollock BE. Stereotactic radiosurgery in patients with glomus jugulare tumors. Neurosurg Focus. 2004;17(2):E10.
Fayad JN, Schwartz MS, Brackmann DE. Treatment of recurrent and residual glomus jugulare tumors. Skull Base: Off J N Am Skull Base Soc [et al]. 2009;19(1):92–8.
Financial Material and Support
No funding or other support was required for this study.
To assist the reader in gaining familiarity with available evidence, the following rating system has been used to indicate key references for each chapter’s content:
***: Critical material. Anyone dealing with this condition should be familiar with this reference.
**: Useful material. Important information that is valuable in in clinical or scientific practice related to this condition.
*: Optional material. For readers with a strong interest in the chapter content or a desire to study it in greater depth.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Carlson, M.L., Sweeney, A.D., Patel, N.S., Wanna, G.B. (2018). Temporal Bone Paraganglioma. In: Perkins, J., Balakrishnan, K. (eds) Evidence-Based Management of Head and Neck Vascular Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-319-92306-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-92306-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92305-5
Online ISBN: 978-3-319-92306-2
eBook Packages: MedicineMedicine (R0)